Maintaining Fat-Free Mass and Muscle Mass during obesity therapy with Incretin-Mimetic Drugs

Maintaining Fat-Free Mass and Muscle Mass during obesity therapy with Incretin-Mimetic Drugs

Obesity is one of the major public health challenges of the 21st century. In recent years, incretin mimetic drugs (IMDs), primarily liraglutide, semaglutide, and tirzepatide, have gained popularity due to their ability to help patients lose 10%-20% of their body weight. However, it has been observe...

Full description

Saved in:
Bibliographic Details
Main Authors: Dariusz Popiela, Karina Urbańska, Łukasz Stojak, Mateusz Grego, Filip Kwiatkowski, Mateusz Baczewski, Katarzyna Grego, Witold Czyż
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2025-01-01
Series:Quality in Sport
Subjects:
obesity treatment
physical activity
Nutrition
dual GLP-1/GIP receptor agonist
GLP-1 analog
muscle mass
Online Access:https://apcz.umk.pl/QS/article/view/57000
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://apcz.umk.pl/QS/article/view/57000

Similar Items